Intellectual Property Implications of the Medical Wearable and Wellness Device Revolution for Startups | MD+DI

The U.S. Food and Drug Administration (FDA) has increasingly emphasized the use of real-world evidence (RWE) to support regulatory decision-making for medical devices. As medical technologies evolve and data sources...

Johnson & Johnson (J&J) reported on April 24, 2026, that it has entered into an agreement to acquire Atraverse Medical, a company in the cardiovascular medical device sector, for an undisclosed amount. The deal...

Epineuron Technologies, a Canada-based clinical-stage nerve care company developing a bioelectronic therapy for the treatment of injured peripheral nerves, announced on May 12 that it has received 510(k) clearance of its Evala® Nerve Stimulator from the...